Missense	O
mutation	O
in	O
exon	B-DNA
7	I-DNA
of	O
the	O
common	B-DNA
gamma	I-DNA
chain	I-DNA
gene	I-DNA
causes	O
a	O
moderate	O
form	O
of	O
X-linked	O
combined	O
immunodeficiency	O
.	O

Clinical	O
and	O
immunologic	O
features	O
of	O
a	O
recently	O
recognized	O
X-linked	O
combined	O
immunodeficiency	O
disease	O
(	O
XCID	O
)	O
suggested	O
that	O
XCID	O
and	O
X-linked	O
severe	O
combined	O
immunodeficiency	O
(	O
XSCID	O
)	O
might	O
arise	O
from	O
different	O
genetic	O
defects	O
.	O

The	O
recent	O
discovery	O
of	O
mutations	O
in	O
the	O
common	B-DNA
gamma	I-DNA
chain	I-DNA
(	I-DNA
gamma	I-DNA
c	I-DNA
)	I-DNA
gene	I-DNA
,	O
a	O
constituent	O
of	O
several	O
cytokine	B-protein
receptors	I-protein
,	O
in	O
XSCID	O
provided	O
an	O
opportunity	O
to	O
test	O
directly	O
whether	O
a	O
previously	O
unrecognized	O
mutation	O
in	O
this	O
same	O
gene	O
was	O
responsible	O
for	O
XCID	O
.	O

The	O
status	O
of	O
X	B-DNA
chromosome	I-DNA
inactivation	O
in	O
blood	O
leukocytes	O
from	O
obligate	O
carriers	O
of	O
XCID	O
was	O
determined	O
from	O
the	O
polymorphic	O
,	O
short	O
tandem	O
repeats	O
(	O
CAG	O
)	O
,	O
in	O
the	O
androgen	B-DNA
receptor	I-DNA
gene	I-DNA
,	O
which	O
also	O
contains	O
a	O
methylation-sensitive	B-DNA
HpaII	I-DNA
site	I-DNA
.	O

As	O
in	O
XSCID	O
,	O
X-chromosome	O
inactivation	O
in	O
obligate	O
carriers	O
of	O
XCID	O
was	O
nonrandom	O
in	O
T	B-cell_type
and	I-cell_type
B	I-cell_type
lymphocytes	I-cell_type
.	O

In	O
addition	O
,	O
X	B-DNA
chromosome	I-DNA
inactivation	O
in	O
PMNs	O
was	O
variable	O
.	O

Findings	O
from	O
this	O
analysis	O
prompted	O
sequencing	O
of	O
the	O
gamma	B-DNA
c	I-DNA
gene	I-DNA
in	O
this	O
pedigree	O
.	O

A	O
missense	O
mutation	O
in	O
the	O
region	O
coding	O
for	O
the	O
cytoplasmic	O
portion	O
of	O
the	O
gamma	B-DNA
c	I-DNA
gene	I-DNA
was	O
found	O
in	O
three	O
affected	O
males	O
but	O
not	O
in	O
a	O
normal	O
brother	O
.	O

Therefore	O
,	O
this	O
point	O
mutation	O
in	O
the	O
gamma	B-DNA
c	I-DNA
gene	I-DNA
leads	O
to	O
a	O
less	O
severe	O
degree	O
of	O
deficiency	O
in	O
cellular	O
and	O
humoral	O
immunity	O
than	O
that	O
seen	O
in	O
XSCID	O
.	O

Missense	NULL
Mutation	NULL
in	NULL
Exon	NULL
7	NULL
of	NULL
the	NULL
Common	NULL
y	NULL
Chain	NULL
Gene	NULL
Causes	NULL
a	NULL
Moderate	NULL
Form	NULL
of	NULL
X-linked	NULL
Combined	NULL
Immunodeficiency	NULL
Frank	NULL
C.	NULL
Schmalstieg	NULL
,	NULL
**	NULL
Warren	NULL
J.	NULL
Leonard	NULL
,	NULL
Masayuki	NULL
Noguchi	NULL
,	NULL
``	NULL
Maria	NULL
Berg	NULL
,	NULL
``	NULL
H.	NULL
Elizabeth	NULL
Rudioff	NULL
,	NULL
*	NULL
Richard	NULL
M.	NULL
Denney	NULL
,	NULL
*	NULL
Sanat	NULL
K.	NULL
Dave	NULL
,	NULL
*	NULL
Edward	NULL
G.	NULL
Brooks	NULL
,	NULL
*	NULL
and	NULL
Armond	NULL
S.	NULL
Goldman**	NULL
Departments	NULL
of	NULL
*Pediatrics	NULL
,	NULL
*Human	NULL
Biological	NULL
Chemistry	NULL
and	NULL
Genetics	NULL
,	NULL
and	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
Medical	NULL
Branch	NULL
,	NULL
Galveston	NULL
,	NULL
Texas	NULL
77555-0369	NULL
;	NULL
and	NULL
the	NULL
``	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Immunology	NULL
,	NULL
National	NULL
Heart	NULL
,	NULL
Lung	NULL
,	NULL
and	NULL
Blood	NULL
Institute	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
Abstract	NULL
Clinical	NULL
and	NULL
immunologic	NULL
features	NULL
of	NULL
a	NULL
recently	NULL
recognized	NULL
X-linked	NULL
combined	NULL
immunodeficiency	NULL
disease	NULL
(	NULL
XCID	NULL
)	NULL
suggested	NULL
that	NULL
XCID	NULL
and	NULL
X-linked	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
(	NULL
XSCID	NULL
)	NULL
might	NULL
arise	NULL
from	NULL
different	NULL
genetic	NULL
defects	NULL
.	NULL

The	NULL
recent	NULL
discovery	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
common	NULL
y	NULL
chain	NULL
(	NULL
y	NULL
.	NULL
)	NULL

gene	NULL
,	NULL
a	NULL
constituent	NULL
of	NULL
several	NULL
cytokine	NULL
receptors	NULL
,	NULL
in	NULL
XSCID	NULL
provided	NULL
an	NULL
opportunity	NULL
to	NULL
test	NULL
directly	NULL
whether	NULL
a	NULL
previously	NULL
unrecognized	NULL
mutation	NULL
in	NULL
this	NULL
same	NULL
gene	NULL
was	NULL
responsible	NULL
for	NULL
XCID	NULL
.	NULL

The	NULL
status	NULL
of	NULL
X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
blood	NULL
leukocytes	NULL
from	NULL
obligate	NULL
carriers	NULL
of	NULL
XCID	NULL
was	NULL
determined	NULL
from	NULL
the	NULL
polymorphic	NULL
,	NULL
short	NULL
tandem	NULL
repeats	NULL
(	NULL
CAG	NULL
)	NULL
,	NULL
in	NULL
the	NULL
androgen	NULL
receptor	NULL
gene	NULL
,	NULL
which	NULL
also	NULL
contains	NULL
a	NULL
methylation-sensitive	NULL
Hpall	NULL
site	NULL
.	NULL

As	NULL
in	NULL
XSCID	NULL
,	NULL
X-chromosome	NULL
inactivation	NULL
in	NULL
obligate	NULL
carriers	NULL
of	NULL
XCID	NULL
was	NULL
nonrandom	NULL
in	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
PMNs	NULL
was	NULL
variable	NULL
.	NULL

Findings	NULL
from	NULL
this	NULL
analysis	NULL
prompted	NULL
sequencing	NULL
of	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
in	NULL
this	NULL
pedigree	NULL
.	NULL

A	NULL
missense	NULL
mutation	NULL
in	NULL
the	NULL
region	NULL
coding	NULL
for	NULL
the	NULL
cytoplasmic	NULL
portion	NULL
of	NULL
the	NULL
7	NULL
,	NULL
gene	NULL
was	NULL
found	NULL
in	NULL
three	NULL
affected	NULL
males	NULL
but	NULL
not	NULL
in	NULL
a	NULL
normal	NULL
brother	NULL
.	NULL

Therefore	NULL
,	NULL
this	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
leads	NULL
to	NULL
a	NULL
less	NULL
severe	NULL
degree	NULL
of	NULL
deficiency	NULL
in	NULL
cellular	NULL
and	NULL
humoral	NULL
immunity	NULL
than	NULL
that	NULL
seen	NULL
in	NULL
XSCID	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1995	NULL
.	NULL

95:1169-1173	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
T	NULL
lympho-cyte	NULL
«	NULL
immunodeficiency	NULL
«	NULL
IL-2R	NULL
«	NULL
X	NULL
chromosome	NULL
«	NULL
genetics	NULL
Introduction	NULL
In	NULL
1990	NULL
,	NULL
we	NULL
reported	NULL
a	NULL
novel	NULL
X-linked	NULL
combined	NULL
immunodeficiency	NULL
(	NULL
XCID	NULL
)	NULL
'	NULL
distinct	NULL
from	NULL
X-linked	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
(	NULL
XSCID	NULL
)	NULL
in	NULL
a	NULL
large	NULL
kindred	NULL
of	NULL
English	NULL
origin	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
patients	NULL
displayed	NULL
repeated	NULL
,	NULL
chronic	NULL
bacterial	NULL
infections	NULL
of	NULL
Portions	NULL
of	NULL
this	NULL
work	NULL
appeared	NULL
in	NULL
abstract	NULL
form	NULL
(	NULL
Pediatr	NULL
.	NULL

Res	NULL
.	NULL

35:76A	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Frank	NULL
C.	NULL
Schmalstieg	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Ph.D.	NULL
,	NULL
Division	NULL
of	NULL
Immunology	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
The	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Room	NULL
C-236	NULL
,	NULL
The	NULL
University	NULL
of	NULL
Texas	NULL
Medical	NULL
Branch	NULL
,	NULL
Galveston	NULL
,	NULL
TX	NULL
77555-0369	NULL
.	NULL

FAX	NULL
:	NULL
409-772-5045	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
20	NULL
September	NULL
1994	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
10	NULL
November	NULL
1994	NULL
.	NULL

1	NULL
.	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
AR	NULL
,	NULL
androgen	NULL
receptor	NULL
;	NULL
y	NULL
,	NULL
,	NULL
common	NULL
y	NULL
chain	NULL
;	NULL
SSCP	NULL
,	NULL
single-stranded	NULL
conformational	NULL
polymorphisms	NULL
;	NULL
XCID	NULL
,	NULL
X-linked	NULL
combined	NULL
immunodeficiency	NULL
;	NULL
XSCID	NULL
,	NULL
X-linked	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
Volume	NULL
95	NULL
,	NULL
March	NULL
1995	NULL
,	NULL
1169-1173	NULL
the	NULL
middle	NULL
ear	NULL
,	NULL
paranasal	NULL
sinuses	NULL
,	NULL
bronchi	NULL
,	NULL
and	NULL
lungs	NULL
as	NULL
well	NULL
as	NULL
severe	NULL
or	NULL
recurrent	NULL
varicella	NULL
,	NULL
Herpes	NULL
simplex	NULL
,	NULL
and	NULL
papilloma	NULL
virus	NULL
infections	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
XSCID	NULL
,	NULL
other	NULL
opportunistic	NULL
infections	NULL
including	NULL
Prewumocystis	NULL
carrini	NULL
pneumonia	NULL
were	NULL
not	NULL
seen	NULL
,	NULL
and	NULL
some	NULL
affected	NULL
males	NULL
survived	NULL
into	NULL
late	NULL
childhood	NULL
or	NULL
adult-hood	NULL
.	NULL

This	NULL
spectrum	NULL
of	NULL
infections	NULL
suggested	NULL
that	NULL
both	NULL
humoral	NULL
and	NULL
cellular	NULL
immunity	NULL
were	NULL
deficient	NULL
,	NULL
but	NULL
not	NULL
to	NULL
the	NULL
degree	NULL
found	NULL
in	NULL
XSCID	NULL
.	NULL

Indeed	NULL
,	NULL
serum	NULL
immunoglobulin	NULL
levels	NULL
were	NULL
normal	NULL
,	NULL
whereas	NULL
they	NULL
are	NULL
decreased	NULL
in	NULL
XSCID	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
specific	NULL
serum	NULL
IgG	NULL
and	NULL
IgA	NULL
antibodies	NULL
was	NULL
,	NULL
however	NULL
,	NULL
profoundly	NULL
diminished	NULL
in	NULL
XCID	NULL
(	NULL
1	NULL
)	NULL
,	NULL
most	NULL
likely	NULL
due	NULL
to	NULL
T	NULL
cell	NULL
defects	NULL
.	NULL

Indeed	NULL
,	NULL
CD4	NULL
and	NULL
CD8	NULL
T	NULL
cells	NULL
were	NULL
significantly	NULL
de-creased	NULL
,	NULL
but	NULL
not	NULL
to	NULL
the	NULL
extent	NULL
seen	NULL
in	NULL
XSCID	NULL
(	NULL
1	NULL
)	NULL
.	NULL

XCID	NULL
also	NULL
differed	NULL
from	NULL
classical	NULL
XSCID	NULL
in	NULL
that	NULL
blood	NULL
T	NULL
cells	NULL
were	NULL
predominantly	NULL
CD4SRO+	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
blood	NULL
CD4+	NULL
T	NULL
cells	NULL
occurred	NULL
postnatally	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
variable	NULL
region	NULL
repertoire	NULL
in	NULL
T	NULL
cell	NULL
receptors	NULL
(	NULL
a/	NULL
)	NULL
on	NULL
blood	NULL
T	NULL
cells	NULL
was	NULL
altered	NULL
in	NULL
the	NULL
affected	NULL
males	NULL
(	NULL
3	NULL
)	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
molecular	NULL
relationships	NULL
between	NULL
XCID	NULL
and	NULL
XSCID	NULL
by	NULL
three	NULL
coupled	NULL
approaches	NULL
.	NULL

First	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
pattern	NULL
of	NULL
X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
blood	NULL
T	NULL
cells	NULL
,	NULL
B-lymphoblastoid	NULL
cells	NULL
and	NULL
PMNs	NULL
from	NULL
obligate	NULL
carriers	NULL
of	NULL
the	NULL
disease	NULL
using	NULL
the	NULL
methylation	NULL
status	NULL
of	NULL
the	NULL
STR	NULL
,	NULL
(	NULL
CAG	NULL
)	NULL
,	NULL
,	NULL
in	NULL
the	NULL
AR	NULL
gene	NULL
,	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
since	NULL
nonrandom	NULL
X	NULL
inactivation	NULL
is	NULL
found	NULL
in	NULL
carriers	NULL
of	NULL
XSCID	NULL
(	NULL
6-8	NULL
)	NULL
.	NULL

Second	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
segregation	NULL
of	NULL
XCID	NULL
was	NULL
closely	NULL
linked	NULL
to	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
,	NULL
because	NULL
mutations	NULL
in	NULL
that	NULL
gene	NULL
are	NULL
responsible	NULL
for	NULL
XSCID	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
segregation	NULL
of	NULL
XCID	NULL
with	NULL
polymorphisms	NULL
of	NULL
the	NULL
androgen	NULL
receptor	NULL
(	NULL
AR	NULL
)	NULL
gene	NULL
(	NULL
Xq11.1	NULL
)	NULL
,	NULL
intron	NULL
1	NULL
of	NULL
the	NULL
common	NULL
y	NULL
chain	NULL
(	NULL
y	NULL
.	NULL
)	NULL

gene	NULL
(	NULL
Xq13	NULL
)	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
,	NULL
and	NULL
the	NULL
dinucleotide	NULL
repeat	NULL
(	NULL
CA	NULL
)	NULL
,	NULL
in	NULL
the	NULL
DXS458	NULL
locus	NULL
(	NULL
Xq23	NULL
)	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
were	NULL
investigated	NULL
for	NULL
this	NULL
purpose	NULL
.	NULL

Finally	NULL
,	NULL
based	NULL
upon	NULL
findings	NULL
from	NULL
those	NULL
studies	NULL
,	NULL
the	NULL
y.	NULL
gene	NULL
from	NULL
males	NULL
affected	NULL
with	NULL
XCID	NULL
was	NULL
sequenced	NULL
to	NULL
determine	NULL
if	NULL
a	NULL
mutation	NULL
was	NULL
present	NULL
.	NULL

Methods	NULL
Subjects	NULL
.	NULL

The	NULL
study	NULL
was	NULL
approved	NULL
by	NULL
the	NULL
Institutional	NULL
Review	NULL
Board	NULL
of	NULL
the	NULL
University	NULL
of	NULL
Texas	NULL
Medical	NULL
Branch	NULL
.	NULL

All	NULL
subjects	NULL
gave	NULL
informed	NULL
consent	NULL
for	NULL
the	NULL
study	NULL
.	NULL

B-lymphoblastoid	NULL
cell	NULL
lines	NULL
from	NULL
all	NULL
available	NULL
carriers	NULL
and	NULL
affected	NULL
males	NULL
,	NULL
and	NULL
T	NULL
cells	NULL
and	NULL
PMNs	NULL
from	NULL
six	NULL
obligate	NULL
carriers	NULL
were	NULL
investigated	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

All	NULL
the	NULL
available	NULL
carriers	NULL
were	NULL
in	NULL
good	NULL
health	NULL
without	NULL
evidence	NULL
of	NULL
infection	NULL
at	NULL
the	NULL
time	NULL
they	NULL
were	NULL
studied	NULL
.	NULL

Subjects	NULL
used	NULL
for	NULL
linkage	NULL
and	NULL
heteroduplex	NULL
study	NULL
were	NULL
chosen	NULL
based	NULL
on	NULL
their	NULL
lineage	NULL
and	NULL
availability	NULL
.	NULL

The	NULL
three	NULL
affected	NULL
males	NULL
whose	NULL
genomic	NULL
DNA	NULL
was	NULL
sequenced	NULL
,	NULL
were	NULL
used	NULL
because	NULL
they	NULL
each	NULL
represented	NULL
a	NULL
separate	NULL
branch	NULL
of	NULL
this	NULL
family	NULL
with	NULL
affected	NULL
males	NULL
.	NULL

DNA	NULL
isolation	NULL
.	NULL

Mononuclear	NULL
cells	NULL
and	NULL
PMNs	NULL
were	NULL
prepared	NULL
from	NULL
heparinized	NULL
venous	NULL
blood	NULL
by	NULL
dextran	NULL
sedimentation	NULL
and	NULL
Ficoll-Hypaque	NULL
centrifugation	NULL
(	NULL
13	NULL
)	NULL
.	NULL

T	NULL
lymphocytes	NULL
were	NULL
purified	NULL
using	NULL
magnetic	NULL
beads	NULL
coupled	NULL
to	NULL
anti-CD3	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
cell	NULL
preparations	NULL
was	NULL
monitored	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
1	NULL
)	NULL
.	NULL

B-lymph-	NULL
Moderate	NULL
X-linked	NULL
Combined	NULL
Immunodeficiency	NULL
1169	NULL
VI	NULL
Vil	NULL
Figure	NULL
1	NULL
.	NULL

Pedigree	NULL
of	NULL
the	NULL
kindred	NULL
with	NULL
XCID	NULL
.	NULL

The	NULL
key	NULL
for	NULL
the	NULL
symbols	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
Obligate	NULL
carrier	NULL
females	NULL
(	NULL
@	NULL
)	NULL
;	NULL
females	NULL
with	NULL
suspected	NULL
carrier	NULL
status	NULL
based	NULL
on	NULL
non-random	NULL
X-inactivation	NULL
(	NULL
@	NULL
)	NULL
;	NULL
affected	NULL
males	NULL
(	NULL
m	NULL
)	NULL
;	NULL
miscarriage	NULL
(	NULL
«	NULL
)	NULL
.	NULL

A	NULL
diagonal	NULL
line	NULL
represents	NULL
deceased	NULL
family	NULL
mem-bers	NULL
.	NULL

Individuals	NULL
shown	NULL
in	NULL
subsequent	NULL
figures	NULL
are	NULL
identified	NULL
by	NULL
generation	NULL
number	NULL
at	NULL
the	NULL
sides	NULL
of	NULL
the	NULL
chart	NULL
and	NULL
a	NULL
letter	NULL
designation	NULL
within	NULL
generations	NULL
.	NULL

oblastoid	NULL
cell	NULL
lines	NULL
were	NULL
produced	NULL
by	NULL
infection	NULL
of	NULL
blood	NULL
B	NULL
cells	NULL
with	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
15	NULL
)	NULL
.	NULL

DNA	NULL
from	NULL
the	NULL
cell	NULL
preparations	NULL
was	NULL
obtained	NULL
by	NULL
NP-40	NULL
lysis	NULL
,	NULL
proteinase	NULL
K	NULL
digestion	NULL
,	NULL
and	NULL
phenol-chloroform	NULL
extraction	NULL
(	NULL
16	NULL
)	NULL
or	NULL
by	NULL
passage	NULL
through	NULL
DNA	NULL
purification	NULL
columns	NULL
(	NULL
Genomic	NULL
DNA	NULL
Isolation	NULL
Kit	NULL
,	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
directions	NULL
.	NULL

PCR	NULL
amplification	NULL
of	NULL
the	NULL
AR	NULL
gene	NULL
short	NULL
tandem	NULL
repeat	NULL
(	NULL
STR	NULL
)	NULL
and	NULL
the	NULL
dinucleotide	NULL
repeat	NULL
in	NULL
the	NULL
DXS458	NULL
locus	NULL
.	NULL

The	NULL
sense	NULL
(	NULL
5'-TCCAGA-ATCTGTTCCAGAGCGTGC-3	NULL
'	NULL
)	NULL
and	NULL
anti-sense	NULL
(	NULL
5-GCTGTGAAG-GTTGCTGTTCCTCAT-3	NULL
'	NULL
)	NULL
primers	NULL
from	NULL
the	NULL
AR	NULL
gene	NULL
(	NULL
12.5	NULL
pmol	NULL
each	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
250	NULL
ng	NULL
of	NULL
genomic	NULL
DNA	NULL
,	NULL
4	NULL
U	NULL
of	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
,	NULL
250	NULL
uM	NULL
deoxynucleoside	NULL
triphosphates	NULL
(	NULL
dNTPs	NULL
)	NULL
(	NULL
2.5	NULL
4Ci	NULL
[	NULL
P	NULL
]	NULL
dCTP	NULL
[	NULL
3,000	NULL
Ci/umole	NULL
]	NULL
)	NULL
,	NULL
and	NULL
1.5	NULL
mM	NULL
MgC1	NULL
;	NULL
(	NULL
4	NULL
)	NULL
in	NULL
the	NULL
manufacturer	NULL
's	NULL
suggested	NULL
buffer	NULL
(	NULL
Perkin-Elmer	NULL
Cetus	NULL
,	NULL
Norwalk	NULL
,	NULL
CT	NULL
)	NULL
(	NULL
total	NULL
volume	NULL
,	NULL
25	NULL
wl	NULL
)	NULL
.	NULL

DNA	NULL
was	NULL
amplified	NULL
for	NULL
25	NULL
cycles	NULL
at	NULL
95°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
65°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
.	NULL

Amplifications	NULL
were	NULL
preceded	NULL
by	NULL
a	NULL
primary	NULL
denaturation	NULL
step	NULL
(	NULL
95°C	NULL
for	NULL
5	NULL
min	NULL
)	NULL
and	NULL
followed	NULL
by	NULL
a	NULL
final	NULL
extension	NULL
step	NULL
(	NULL
72°C	NULL
for	NULL
8	NULL
min	NULL
)	NULL
after	NULL
the	NULL
last	NULL
cycle	NULL
(	NULL
4	NULL
)	NULL
.	NULL

When	NULL
methylation	NULL
status	NULL
of	NULL
the	NULL
genomic	NULL
DNA	NULL
was	NULL
examined	NULL
by	NULL
digestion	NULL
with	NULL
Hpall	NULL
,	NULL
the	NULL
DNA	NULL
(	NULL
250	NULL
ng	NULL
)	NULL
was	NULL
digested	NULL
with	NULL
Hpall	NULL
(	NULL
Promega	NULL
)	NULL
in	NULL
a	NULL
reaction	NULL
volume	NULL
of	NULL
4	NULL
pl	NULL
(	NULL
in	NULL
the	NULL
manufacturer	NULL
's	NULL
recommended	NULL
buffer	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
(	NULL
17	NULL
)	NULL
before	NULL
amplification	NULL
.	NULL

After	NULL
addition	NULL
of	NULL
stop	NULL
buffer	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
denatured	NULL
at	NULL
95°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
electrophoresed	NULL
on	NULL
4	NULL
%	NULL
polyacrylamide/8M	NULL
urea	NULL
at	NULL
38	NULL
W	NULL
for	NULL
2	NULL
h.	NULL
Resultant	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
,	NULL
or	NULL
by	NULL
radioautography	NULL
using	NULL
Hyper-film-	NULL
MP	NULL
(	NULL
Amersham	NULL
Corp.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

PCR	NULL
conditions	NULL
for	NULL
amplification	NULL
of	NULL
the	NULL
DSX458	NULL
locus	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
The	NULL
sense	NULL
(	NULL
5'-GATAAAACTGCATAGAAATGCG-3	NULL
'	NULL
)	NULL
and	NULL
antisense	NULL
(	NULL
5'-CAACTG-GGATATTGACATTG-3	NULL
'	NULL
)	NULL
primers	NULL
(	NULL
12.5	NULL
pmol	NULL
each	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
20	NULL
ng	NULL
of	NULL
genomic	NULL
DNA	NULL
,	NULL
1	NULL
unit	NULL
of	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
,	NULL
200	NULL
LM	NULL
dNTPs	NULL
(	NULL
2.5	NULL
uCi	NULL
{	NULL
P	NULL
]	NULL
dCTP	NULL
[	NULL
3,000	NULL
Ci/umole	NULL
]	NULL
)	NULL
,	NULL
and	NULL
1.5	NULL
mM	NULL
MgCl	NULL
;	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Analyses	NULL
of	NULL
polymorphisms	NULL
of	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
.	NULL

SSCP	NULL
analyses	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Sense	NULL
(	NULL
5-GAATGAAGACAC-CACAGCTG-3	NULL
'	NULL
)	NULL
and	NULL
anti-sense	NULL
(	NULL
5'-GGGCATAGTGGTCAGGAAG-3	NULL
'	NULL
)	NULL
primers	NULL
from	NULL
intron	NULL
1	NULL
of	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
(	NULL
1	NULL
uM	NULL
each	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
200	NULL
ng	NULL
of	NULL
genomic	NULL
DNA	NULL
,	NULL
0.45	NULL
U	NULL
of	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
,	NULL
200	NULL
uM	NULL
deoxynucleoside	NULL
triphosphates	NULL
(	NULL
dNTPs	NULL
)	NULL
,	NULL
25	NULL
uM	NULL
dCTP	NULL
with	NULL
1	NULL
4Ci	NULL
of	NULL
[	NULL
P	NULL
]	NULL
dCTP	NULL
and	NULL
1.0	NULL
mM	NULL
MgCl	NULL
;	NULL
in	NULL
the	NULL
manufacturer	NULL
's	NULL
suggested	NULL
buffer	NULL
(	NULL
Perkin-Elmer	NULL
Cetus	NULL
,	NULL
Norwalk	NULL
,	NULL
CT	NULL
)	NULL
(	NULL
total	NULL
volume	NULL
,	NULL
15	NULL
pl	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
denatured	NULL
(	NULL
94°C	NULL
for	NULL
5	NULL
min	NULL
)	NULL
,	NULL
amplified	NULL
for	NULL
30	NULL
cycles	NULL
at	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
55°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
and	NULL
followed	NULL
by	NULL
a	NULL
final	NULL
extension	NULL
step	NULL
(	NULL
72°C	NULL
for	NULL
7	NULL
min	NULL
)	NULL
after	NULL
the	NULL
last	NULL
cycle	NULL
.	NULL

After	NULL
addition	NULL
of	NULL
stop	NULL
buffer	NULL
(	NULL
USB	NULL
)	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
denatured	NULL
at	NULL
95°C	NULL
for	NULL
10	NULL
min	NULL
,	NULL
1170	NULL
Schmalstieg	NULL
et	NULL
al	NULL
.	NULL

quenched	NULL
in	NULL
an	NULL
ice	NULL
bath	NULL
,	NULL
and	NULL
4-ul	NULL
aliquots	NULL
electrophoresed	NULL
on	NULL
non-denaturing	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
at	NULL
constant	NULL
power	NULL
(	NULL
25	NULL
W	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
or	NULL
at	NULL
4°C	NULL
for	NULL
2	NULL
h.	NULL
After	NULL
drying	NULL
,	NULL
the	NULL
resultant	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
on	NULL
Hyperfilim-MP	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
exposed	NULL
for	NULL
30	NULL
min	NULL
to	NULL
1	NULL
h	NULL
at	NULL
-70°C	NULL
.	NULL

For	NULL
heteroduplex	NULL
formation	NULL
,	NULL
4	NULL
ul	NULL
of	NULL
PCR	NULL
amplification	NULL
products	NULL
described	NULL
in	NULL
the	NULL
SSCP	NULL
analysis	NULL
were	NULL
mixed	NULL
in	NULL
pairs	NULL
and	NULL
heated	NULL
to	NULL
95°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
allowed	NULL
to	NULL
cool	NULL
slowly	NULL
to	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
then	NULL
added	NULL
to	NULL
3	NULL
Ll	NULL
of	NULL
loading	NULL
buffer	NULL
(	NULL
15	NULL
%	NULL
Ficol	NULL
,	NULL
0.05	NULL
%	NULL
bromophe-nol	NULL
blue	NULL
,	NULL
and	NULL
0.05	NULL
%	NULL
xylene	NULL
cyanol	NULL
)	NULL
and	NULL
4	NULL
wl	NULL
of	NULL
this	NULL
mixture	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
non-denaturing	NULL
electrophoresis	NULL
as	NULL
described	NULL
for	NULL
the	NULL
SSCP	NULL
analysis	NULL
.	NULL

Sequencing	NULL
of	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
.	NULL

Genomic	NULL
DNA	NULL
from	NULL
EBV	NULL
B	NULL
lymphocytes	NULL
was	NULL
utilized	NULL
for	NULL
nested-PCR	NULL
amplifications	NULL
of	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
and	NULL
subsequent	NULL
dideoxy	NULL
chain	NULL
termination	NULL
sequencing	NULL
(	NULL
9	NULL
)	NULL
.	NULL

For	NULL
two	NULL
patients	NULL
,	NULL
exon	NULL
7	NULL
was	NULL
sequenced	NULL
on	NULL
the	NULL
Applied	NULL
Biosystems	NULL
Model	NULL
373A	NULL
automated	NULL
sequencing	NULL
system	NULL
(	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
the	NULL
PRISM	NULL
**	NULL
Ready	NULL
Reaction	NULL
DyeDeoxy	NULL
*	NULL
``	NULL
Terminator	NULL
Cycle	NULL
Sequencing	NULL
Kit	NULL
(	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
directions	NULL
.	NULL

Results	NULL
X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
obligate	NULL
carriers	NULL
.	NULL

Flow	NULL
cytometry	NULL
(	NULL
FACScan®	NULL
,	NULL
Becton-Dickinson	NULL
,	NULL
Moutainview	NULL
CA	NULL
)	NULL
(	NULL
1	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
on	NULL
blood	NULL
lymphocytes	NULL
from	NULL
three	NULL
healthy	NULL
carriers	NULL
.	NULL

The	NULL
results	NULL
(	NULL
mean+standard	NULL
deviation	NULL
;	NULL
normal	NULL
values	NULL
in	NULL
paren-theses	NULL
)	NULL
revealed	NULL
normal	NULL
profiles	NULL
of	NULL
blood	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
NK	NULL
cells	NULL
[	NULL
CD3+	NULL
,	NULL
80+13	NULL
(	NULL
70+7	NULL
)	NULL
;	NULL
CD4+	NULL
,	NULL
40+9	NULL
(	NULL
40+6	NULL
)	NULL
;	NULL
CD8+	NULL
,	NULL
28+12	NULL
(	NULL
21+6	NULL
)	NULL
;	NULL
CD19+	NULL
,	NULL
13+3	NULL
(	NULL
12+6	NULL
)	NULL
;	NULL
CD16+	NULL
,	NULL
4+1	NULL
(	NULL
12+5	NULL
)	NULL
.	NULL
]	NULL

In	NULL
addition	NULL
,	NULL
over	NULL
95	NULL
%	NULL
of	NULL
blood	NULL
T	NULL
cells	NULL
from	NULL
two	NULL
carriers	NULL
that	NULL
were	NULL
tested	NULL
were	NULL
TCR	NULL
a/	NULL
@	NULL
+	NULL
.	NULL

Products	NULL
from	NULL
the	NULL
AR	NULL
gene	NULL
ranging	NULL
from	NULL
~	NULL
280	NULL
to	NULL
310	NULL
bp	NULL
were	NULL
produced	NULL
by	NULL
amplification	NULL
of	NULL
genomic	NULL
DNA	NULL
from	NULL
T	NULL
lymphocytes	NULL
,	NULL
B-lymphoblastoid	NULL
cells	NULL
,	NULL
and	NULL
PMNs	NULL
of	NULL
six	NULL
obligate	NULL
carriers	NULL
.	NULL

When	NULL
the	NULL
genomic	NULL
DNA	NULL
was	NULL
digested	NULL
with	NULL
Hpall	NULL
,	NULL
one	NULL
band	NULL
predominated	NULL
in	NULL
the	NULL
amplified	NULL
DNA	NULL
from	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
and	NULL
B-lymphoblastoid	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
,	NULL
but	NULL
both	NULL
bands	NULL
were	NULL
variably	NULL
amplified	NULL
in	NULL
the	NULL
case	NULL
of	NULL
PMNs	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
)	NULL
.	NULL

Those	NULL
findings	NULL
indicated	NULL
that	NULL
X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
XCID	NULL
carriers	NULL
was	NULL
non-random	NULL
in	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
variable	NULL
in	NULL
PMNs	NULL
from	NULL
obligate	NULL
carriers	NULL
.	NULL

An	NULL
exception	NULL
to	NULL
this	NULL
pattern	NULL
was	NULL
detected	NULL
in	NULL
one	NULL
carrier	NULL
female	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
woman	NULL
exhibited	NULL
nonrandom	NULL
X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
B-lymphoblastoid	NULL
cells	NULL
,	NULL
and	NULL
PMNs	NULL
.	NULL

X	NULL
chromosome	NULL
use	NULL
for	NULL
her	NULL
T	NULL
cells	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
found	NULL
in	NULL
the	NULL
other	NULL
obligate	NULL
carriers	NULL
.	NULL

However	NULL
,	NULL
the	NULL
maternally	NULL
derived	NULL
,	NULL
abnormal	NULL
X	NULL
chromosome	NULL
was	NULL
used	NULL
in	NULL
her	NULL
B-lymphoblastoid	NULL
cells	NULL
and	NULL
PMNs	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Polymorphism	NULL
analyses	NULL
of	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
.	NULL

SSCP	NULL
analysis	NULL
for	NULL
intron	NULL
1	NULL
and	NULL
intron	NULL
2	NULL
of	NULL
the	NULL
y	NULL
,	NULL
was	NULL
uninformative	NULL
.	NULL
``	NULL

However	NULL
,	NULL
heteroduplex	NULL
formation	NULL
between	NULL
distinct	NULL
alleles	NULL
in	NULL
intron	NULL
1	NULL
was	NULL
found	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
VI-O	NULL
,	NULL
an	NULL
affected	NULL
male	NULL
and	NULL
VI-N	NULL
,	NULL
his	NULL
normal	NULL
brother	NULL
)	NULL
by	NULL
mixing	NULL
experiments	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
several	NULL
obligate	NULL
carriers	NULL
also	NULL
demonstrated	NULL
heteroduplexes	NULL
,	NULL
indicating	NULL
heterozy-gosity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
entire	NULL
y	NULL
,	NULL
gene	NULL
was	NULL
sequenced	NULL
for	NULL
individuals	NULL
VI-N	NULL
and	NULL
VI-O	NULL
.	NULL

VI-O	NULL
,	NULL
but	NULL
not	NULL
VI-N	NULL
,	NULL
2	NULL
.	NULL

A	NULL
polymorphism	NULL
in	NULL
intron	NULL
1	NULL
of	NULL
the	NULL
y.	NULL
gene	NULL
detected	NULL
by	NULL
SSCP	NULL
analysis	NULL
was	NULL
previously	NULL
reported	NULL
in	NULL
abstract	NULL
form	NULL
(	NULL
Pediatr	NULL
.	NULL

Res	NULL
.	NULL

35:76A	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

This	NULL
apparent	NULL
polymorphism	NULL
was	NULL
secondary	NULL
to	NULL
heteroduplex	NULL
formation	NULL
under	NULL
the	NULL
conditions	NULL
the	NULL
assay	NULL
was	NULL
performed	NULL
.	NULL

If	NULL
the	NULL
assay	NULL
is	NULL
performed	NULL
under	NULL
conditions	NULL
precluding	NULL
heteroduplex	NULL
formation	NULL
,	NULL
no	NULL
polymorphism	NULL
by	NULL
SSCP	NULL
analysis	NULL
is	NULL
observed	NULL
.	NULL

-Hpa	NULL
II	NULL
+Hpa	NULL
II	NULL
-Hpa	NULL
II	NULL
+Hpa	NULL
II	NULL
Trp	NULL
a	NULL
arse	NULL
VI-P_V-H	NULL
VIO	NULL
VI-P	NULL
V-H	NULL
VI-P	NULL
V-O	NULL
IV-1	NULL
VLP	NULL
V-O	NULL
IV	NULL
-Hpa	NULL
II	NULL
+Hpa	NULL
II	NULL
2s	NULL
soma	NULL
on	NULL
laitos	NULL
]	NULL
VI-P	NULL
V-O0	NULL
VI-P	NULL
V-O	NULL
Figure	NULL
2	NULL
.	NULL

X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
blood	NULL
T	NULL
lymphocytes	NULL
,	NULL
B-lymphoblastoid	NULL
cells	NULL
,	NULL
and	NULL
PMNs	NULL
using	NULL
the	NULL
methylation	NULL
status	NULL
of	NULL
the	NULL
(	NULL
CAG	NULL
)	NULL
,	NULL
STR	NULL
loci	NULL
of	NULL
the	NULL
AR	NULL
gene	NULL
.	NULL

Genomic	NULL
DNA	NULL
was	NULL
digested	NULL
or	NULL
not	NULL
digested	NULL
with	NULL
Hpall	NULL
before	NULL
amplification	NULL
.	NULL

The	NULL
310-	NULL
and	NULL
280-bp	NULL
polymorphisms	NULL
were	NULL
then	NULL
demonstrated	NULL
by	NULL
autoradiography	NULL
after	NULL
electrophoresis	NULL
in	NULL
4	NULL
%	NULL
polyacrylamide/8	NULL
M	NULL
urea	NULL
gels	NULL
.	NULL

Five	NULL
different	NULL
alleles	NULL
for	NULL
the	NULL
AR	NULL
gene	NULL
were	NULL
represented	NULL
in	NULL
this	NULL
family	NULL
.	NULL

(	NULL
A	NULL
)	NULL
T	NULL
lymphocytes	NULL
:	NULL
The	NULL
310-	NULL
and	NULL
280-bp	NULL
polymorphisms	NULL
were	NULL
demonstrated	NULL
in	NULL
two	NULL
females	NULL
(	NULL
V-H	NULL
and	NULL
VI-P	NULL
)	NULL
before	NULL
Hpall	NULL
digestion	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
the	NULL
lower	NULL
band	NULL
was	NULL
absent	NULL
after	NULL
Hpall	NULL
digestion	NULL
,	NULL
indicating	NULL
nonrandom	NULL
X-inactivation	NULL
and	NULL
that	NULL
the	NULL
310-bp	NULL
band	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
maternal	NULL
X	NULL
chromosome	NULL
.	NULL

An	NULL
affected	NULL
male	NULL
,	NULL
VI-O	NULL
,	NULL
son	NULL
of	NULL
V-O	NULL
exhibited	NULL
the	NULL
280-bp	NULL
band	NULL
and	NULL
indicated	NULL
a	NULL
crossover	NULL
event	NULL
involving	NULL
the	NULL
AR	NULL
locus	NULL
.	NULL

(	NULL
B	NULL
)	NULL
B	NULL
lymphocytes	NULL
:	NULL
the	NULL
280-and	NULL
310-bp	NULL
polymorphisms	NULL
were	NULL
found	NULL
in	NULL
EBV-transformed	NULL
lymphocytes	NULL
from	NULL
carriers	NULL
VI-P	NULL
and	NULL
V-O	NULL
,	NULL
but	NULL
a	NULL
slightly	NULL
higher	NULL
molecular	NULL
weight	NULL
lower	NULL
band	NULL
is	NULL
seen	NULL
in	NULL
carrier	NULL
IV-I	NULL
.	NULL

Only	NULL
the	NULL
310-bp	NULL
band	NULL
is	NULL
visible	NULL
when	NULL
DNA	NULL
from	NULL
these	NULL
carriers	NULL
was	NULL
digested	NULL
with	NULL
Hpall	NULL
before	NULL
amplification	NULL
indicating	NULL
non-random	NULL
X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
these	NULL
lymphoblastoid	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
)	NULL
PMNs	NULL
:	NULL
The	NULL
310-	NULL
and	NULL
280-bp	NULL
bands	NULL
were	NULL
present	NULL
in	NULL
differing	NULL
amounts	NULL
after	NULL
Hpall	NULL
digestion	NULL
of	NULL
DNA	NULL
from	NULL
carriers	NULL
VI-P	NULL
and	NULL
V-O	NULL
.	NULL

This	NULL
is	NULL
representative	NULL
of	NULL
other	NULL
carriers	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
indicates	NULL
variable	NULL
X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
PMNs	NULL
.	NULL

demonstrated	NULL
a	NULL
missense	NULL
mutation	NULL
at	NULL
amino	NULL
acid	NULL
271	NULL
(	NULL
leucine	NULL
>	NULL
glutamine	NULL
)	NULL
corresponding	NULL
to	NULL
a	NULL
(	NULL
CTG	NULL
-	NULL
CAG	NULL
)	NULL
change	NULL
in	NULL
exon	NULL
7	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Subsequent	NULL
sequencing	NULL
of	NULL
two	NULL
additional	NULL
affected	NULL
males	NULL
(	NULL
V-F	NULL
and	NULL
VI-A	NULL
)	NULL
confirmed	NULL
the	NULL
same	NULL
mutation	NULL
in	NULL
the	NULL
SH2	NULL
subdomain	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Genetic	NULL
analysis	NULL
of	NULL
XCID	NULL
.	NULL

Polymorphisms	NULL
in	NULL
the	NULL
AR	NULL
gene	NULL
,	NULL
T	NULL
Cells	NULL
PMNs	NULL
B	NULL
Cells	NULL
igs	NULL
Figure	NULL
3	NULL
.	NULL

Alternative	NULL
X	NULL
chromosome	NULL
usage	NULL
for	NULL
blood	NULL
T	NULL
lymphocytes	NULL
and	NULL
EBV-transformed	NULL
B	NULL
lymphocytes	NULL
and	NULL
PMNs	NULL
in	NULL
one	NULL
female	NULL
carrier	NULL
.	NULL

X	NULL
chromosome	NULL
inactivation	NULL
was	NULL
non-random	NULL
in	NULL
T	NULL
e	NULL
**	NULL
#	NULL
.	NULL

:	NULL
#	NULL
pss	NULL
.	NULL

.	NULL

Q	NULL
Q	NULL
des	NULL
cells	NULL
,	NULL
B-lymphoblastoid	NULL
'	NULL
cells	NULL
,	NULL
and	NULL
PMNs	NULL
.	NULL

T	NULL
cells	NULL
e	NULL
used	NULL
the	NULL
paternally	NULL
derived	NULL
X	NULL
chromosome	NULL
and	NULL
B-lymphoblastoid	NULL
cells	NULL
and	NULL
PMNs	NULL
used	NULL
the	NULL
maternally	NULL
derived	NULL
X	NULL
chromosome	NULL
.	NULL

The	NULL
+	NULL
and	NULL
-	NULL
designations	NULL
are	NULL
for	NULL
digestion	NULL
or	NULL
no	NULL
digestion	NULL
,	NULL
respectively	NULL
,	NULL
with	NULL
Hpall	NULL
before	NULL
PCR	NULL
amplification	NULL
of	NULL
the	NULL
STR	NULL
in	NULL
the	NULL
AR	NULL
gene	NULL
.	NULL

VI-N	NULL
VIO	NULL
_	NULL
VEN	NULL
VO	NULL
VEN	NULL
VO	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
VI-L	NULL
_	NULL
VHL	NULL
MLB	NULL
VIB	NULL
N	NULL
PHEV	NULL
N-	NULL
viN	NULL
vo	NULL
.	NULL

vio	NULL
Heteroduplexes	NULL
I	NULL
:	NULL
win	NULL
ws	NULL
we	NULL
«	NULL
@	NULL
&	NULL
-	NULL
a	NULL
#	NULL
...	NULL
..	NULL

Figure	NULL
4	NULL
.	NULL

Heteroduplex	NULL
analysis	NULL
of	NULL
intron	NULL
1	NULL
of	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
.	NULL

(	NULL
Left	NULL
)	NULL
Heteroduplex	NULL
formation	NULL
between	NULL
affected	NULL
(	NULL
VI-O	NULL
)	NULL
and	NULL
non-affected	NULL
(	NULL
VI-N	NULL
)	NULL
males	NULL
.	NULL

N	NULL
is	NULL
a	NULL
normal	NULL
unaffected	NULL
male	NULL
not	NULL
found	NULL
in	NULL
the	NULL
pedigree	NULL
.	NULL

In	NULL
this	NULL
analysis	NULL
,	NULL
each	NULL
allele	NULL
was	NULL
amplified	NULL
separately	NULL
and	NULL
then	NULL
mixed	NULL
(	NULL
VI-O	NULL
+	NULL
VI-N	NULL
)	NULL
.	NULL

(	NULL
Right	NULL
)	NULL
Confirmation	NULL
of	NULL
carrier	NULL
status	NULL
by	NULL
heteroduplex	NULL
formation	NULL
.	NULL

In	NULL
this	NULL
analysis	NULL
,	NULL
DNA	NULL
from	NULL
either	NULL
VI-N	NULL
or	NULL
VI-O	NULL
was	NULL
mixed	NULL
with	NULL
females	NULL
VII-B	NULL
or	NULL
VI-L	NULL
before	NULL
amplification	NULL
.	NULL

The	NULL
amplified	NULL
products	NULL
were	NULL
subjected	NULL
to	NULL
heteroduplex	NULL
formation	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
,	NULL
and	NULL
VII-B	NULL
,	NULL
but	NULL
not	NULL
VI-L	NULL
,	NULL
was	NULL
confirmed	NULL
to	NULL
be	NULL
a	NULL
carrier	NULL
.	NULL

Note	NULL
that	NULL
mixing	NULL
experiments	NULL
are	NULL
not	NULL
necessary	NULL
in	NULL
those	NULL
females	NULL
who	NULL
are	NULL
heterozygous	NULL
at	NULL
this	NULL
locus	NULL
since	NULL
heteroduplexes	NULL
form	NULL
from	NULL
the	NULL
two	NULL
different	NULL
alleles	NULL
already	NULL
present	NULL
.	NULL

y.	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
DXS458	NULL
locus	NULL
were	NULL
examined	NULL
in	NULL
available	NULL
members	NULL
of	NULL
the	NULL
XCID	NULL
pedigree	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Recombination	NULL
events	NULL
were	NULL
seen	NULL
between	NULL
the	NULL
disease	NULL
locus	NULL
and	NULL
the	NULL
AR	NULL
gene	NULL
,	NULL
but	NULL
not	NULL
the	NULL
DXS458	NULL
locus	NULL
,	NULL
or	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
.	NULL

Two	NULL
other	NULL
affected	NULL
males	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
also	NULL
shared	NULL
the	NULL
same	NULL
y	NULL
,	NULL
gene	NULL
allele	NULL
as	NULL
the	NULL
three	NULL
males	NULL
shown	NULL
.	NULL

Heteroduplex	NULL
analysis	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
occurrence	NULL
of	NULL
the	NULL
disease-associated	NULL
allele	NULL
in	NULL
each	NULL
affected	NULL
male	NULL
and	NULL
certain	NULL
suspected	NULL
carriers	NULL
.	NULL

Chromosomal	NULL
assignments	NULL
of	NULL
the	NULL
alleles	NULL
in	NULL
females	NULL
were	NULL
made	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
least	NULL
numbers	NULL
of	NULL
recombination	NULL
events	NULL
and	NULL
contributions	NULL
of	NULL
the	NULL
paternal	NULL
chromo-somes	NULL
.	NULL

This	NULL
analysis	NULL
allowed	NULL
prediction	NULL
of	NULL
the	NULL
carrier	NULL
status	NULL
of	NULL
these	NULL
individuals	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Discussion	NULL
The	NULL
discovery	NULL
of	NULL
the	NULL
defect	NULL
in	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
in	NULL
XSCID	NULL
(	NULL
9	NULL
)	NULL
provided	NULL
an	NULL
opportunity	NULL
to	NULL
test	NULL
whether	NULL
a	NULL
defect	NULL
in	NULL
the	NULL
same	NULL
gene	NULL
was	NULL
responsible	NULL
for	NULL
XCID	NULL
.	NULL

Single	NULL
stranded	NULL
conformational	NULL
polymorphisms	NULL
were	NULL
sought	NULL
in	NULL
intron	NULL
1	NULL
and	NULL
intron	NULL
2	NULL
of	NULL
the	NULL
y.	NULL
,	NULL
gene	NULL
in	NULL
the	NULL
XCID	NULL
kindred	NULL
.	NULL

This	NULL
analysis	NULL
was	NULL
uninformative	NULL
.	NULL
``	NULL

Further	NULL
evidence	NULL
for	NULL
allelic	NULL
difference	NULL
in	NULL
intron	NULL
1	NULL
was	NULL
examined	NULL
by	NULL
heteroduplex	NULL
analysis	NULL
.	NULL

Mixing	NULL
experiments	NULL
between	NULL
the	NULL
DNA	NULL
from	NULL
an	NULL
affected	NULL
and	NULL
unaffected	NULL
brother	NULL
demonstrated	NULL
heteroduplex	NULL
formation	NULL
.	NULL

This	NULL
strongly	NULL
suggested	NULL
that	NULL
allelic	NULL
differences	NULL
were	NULL
present	NULL
in	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
from	NULL
these	NULL
two	NULL
individuals	NULL
.	NULL

Further	NULL
genetic	NULL
analysis	NULL
employing	NULL
mixing	NULL
experiments	NULL
between	NULL
these	NULL
two	NULL
males	NULL
and	NULL
other	NULL
individuals	NULL
from	NULL
the	NULL
XCID	NULL
pedigree	NULL
was	NULL
consistent	NULL
with	NULL
linkage	NULL
of	NULL
the	NULL
disease	NULL
to	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
.	NULL

Two	NULL
flanking	NULL
loci	NULL
,	NULL
the	NULL
AR	NULL
gene	NULL
and	NULL
the	NULL
DXS458	NULL
loci	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
,	NULL
were	NULL
also	NULL
examined	NULL
in	NULL
this	NULL
family	NULL
.	NULL

Although	NULL
limited	NULL
recombination	NULL
events	NULL
were	NULL
detected	NULL
,	NULL
the	NULL
data	NULL
suggested	NULL
linkage	NULL
to	NULL
these	NULL
loci	NULL
as	NULL
well	NULL
.	NULL

These	NULL
findings	NULL
led	NULL
to	NULL
the	NULL
sequencing	NULL
of	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
in	NULL
one	NULL
of	NULL
the	NULL
affected	NULL
males	NULL
and	NULL
his	NULL
unaffected	NULL
brother	NULL
.	NULL

A	NULL
missense	NULL
mutation	NULL
in	NULL
exon	NULL
7	NULL
(	NULL
10	NULL
,	NULL
19	NULL
)	NULL
(	NULL
leucine	NULL
271-glutamine	NULL
)	NULL
was	NULL
found	NULL
in	NULL
patient	NULL
VI-O	NULL
,	NULL
but	NULL
not	NULL
in	NULL
his	NULL
normal	NULL
brother	NULL
(	NULL
VI-N	NULL
)	NULL
.	NULL

The	NULL
same	NULL
missense	NULL
mutation	NULL
was	NULL
subsequently	NULL
found	NULL
in	NULL
two	NULL
other	NULL
affected	NULL
males	NULL
(	NULL
V-F	NULL
and	NULL
VI-A	NULL
)	NULL
.	NULL

Moderate	NULL
X-linked	NULL
Combined	NULL
Immunodeficiency	NULL
1171	NULL
sp	NULL
MSR	NULL
cytoplasmic	NULL
5	NULL
|	NULL
extracellular	NULL
domain	NULL
_|	NULL
|	NULL
domain	NULL
’	NULL
J	NULL
Ln	NULL
I	NULL
CCC	NULL
)	NULL
-	NULL
.	NULL

|	NULL
yas	NULL
3	NULL
£	NULL
possible	NULL
|	NULL
|	NULL
|	NULL
wap	NULL
e	NULL
g	NULL
Figure	NULL
5	NULL
.	NULL

Missense	NULL
mutation	NULL
in	NULL
exon	NULL
7	NULL
of	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
leucine	NULL
;	NULL
--	NULL
«	NULL
we	NULL
.	NULL

P	NULL
;	NULL
A	NULL
zipper	NULL
same	NULL
__	NULL
ss	NULL
»	NULL
___	NULL
A	NULL
>	NULL
*	NULL
_	NULL
found	NULL
in	NULL
XCID	NULL
.	NULL

(	NULL
A4	NULL
)	NULL
The	NULL
missense	NULL
mutation	NULL
results	NULL
in	NULL
WSXWS	NULL
motif	NULL
-	NULL
|	NULL
Tae	NULL
_	NULL
wake	NULL
__	NULL
|	NULL
_	NULL
the	NULL
replacement	NULL
of	NULL
leucine	NULL
271	NULL
by	NULL
a	NULL
glutamine	NULL
.	NULL

This	NULL
i	NULL
m	NULL
*~	NULL
~	NULL
*~	NULL
-	NULL
:	NULL
mutanfm	NULL
is	NULL
in	NULL
the	NULL
SH2	NULL
sudemam	NULL
homology	NULL
region	NULL
Leucine	NULL
271	NULL
--	NULL
>	NULL
Glutamine	NULL
|	NULL
``	NULL
nung	NULL
,	NULL
*	NULL
aus	NULL
found	NULL
in	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
.	NULL

Interestingly	NULL
,	NULL
Leu	NULL
271	NULL
corresponds	NULL
i	NULL
‘	NULL
L	NULL
cage	NULL
``	NULL
«	NULL
en	NULL
``	NULL
*	NULL
``	NULL
to	NULL
an	NULL
isoleucine	NULL
in	NULL
the	NULL
murine	NULL
y	NULL
,	NULL
sequence	NULL
(	NULL
30	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
PRIPTLKNLEDLVTEYHGNFSAWSGVSKGLAESL	NULL
SH2-subdomain	NULL
homologies	NULL
The	NULL
site	NULL
of	NULL
the	NULL
mutation	NULL
in	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
in	NULL
this	NULL
more	NULL
moderate	NULL
combined	NULL
immunodeficiency	NULL
is	NULL
distinct	NULL
from	NULL
previously	NULL
published	NULL
defects	NULL
in	NULL
this	NULL
gene	NULL
associated	NULL
with	NULL
XSCID	NULL
.	NULL

In	NULL
XSCID	NULL
,	NULL
premature	NULL
stop	NULL
codons	NULL
,	NULL
presumably	NULL
resulting	NULL
in	NULL
truncated	NULL
pro-teins	NULL
,	NULL
were	NULL
reported	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
missense	NULL
mutation	NULL
associated	NULL
with	NULL
XCID	NULL
is	NULL
in	NULL
the	NULL
first	NULL
of	NULL
two	NULL
SH2	NULL
subdomain	NULL
homology	NULL
regions	NULL
of	NULL
the	NULL
cytoplasmic	NULL
portion	NULL
of	NULL
the	NULL
molecule	NULL
(	NULL
10	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Although	NULL
high	NULL
affinity	NULL
IL-2R	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
form	NULL
,	NULL
the	NULL
amino	NULL
acid	NULL
substitution	NULL
in	NULL
a	NULL
phosphopeptide	NULL
binding	NULL
domain	NULL
suggests	NULL
that	NULL
this	NULL
error	NULL
causes	NULL
a	NULL
defective	NULL
association	NULL
of	NULL
this	NULL
receptor	NULL
with	NULL
proteins	NULL
important	NULL
in	NULL
intracellular	NULL
signaling	NULL
.	NULL

Recent	NULL
evidence	NULL
in	NULL
favor	NULL
of	NULL
this	NULL
speculation	NULL
was	NULL
obtained	NULL
re	NULL
IV	NULL
IV	NULL
v	NULL
v	NULL
mn	NULL
9	NULL
hil	NULL
i	NULL
3	NULL
vil	NULL
vil	NULL
C	NULL
1	NULL
s	NULL
Figure	NULL
6	NULL
.	NULL

Genetic	NULL
Analysis	NULL
of	NULL
XCID	NULL
.	NULL

Polymorphisms	NULL
in	NULL
the	NULL
AR	NULL
gene	NULL
,	NULL
y.	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
DXS458	NULL
locus	NULL
were	NULL
examined	NULL
in	NULL
the	NULL
XCID	NULL
pedigree	NULL
.	NULL

Alleles	NULL
were	NULL
assigned	NULL
as	NULL
arbitrary	NULL
numbers	NULL
for	NULL
the	NULL
AR	NULL
gene	NULL
(	NULL
top	NULL
number	NULL
and	NULL
the	NULL
DXS458	NULL
locus	NULL
(	NULL
bottom	NULL
number	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Alleles	NULL
were	NULL
assigned	NULL
to	NULL
the	NULL
maternal	NULL
or	NULL
paternal	NULL
X	NULL
chromosomes	NULL
according	NULL
to	NULL
the	NULL
most	NULL
probably	NULL
inheritance	NULL
patterns	NULL
.	NULL

The	NULL
status	NULL
of	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
was	NULL
designated	NULL
as	NULL
+	NULL
or	NULL
-	NULL
based	NULL
on	NULL
heteroduplex	NULL
analysis	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
more	NULL
than	NULL
two	NULL
alleles	NULL
are	NULL
involved	NULL
in	NULL
this	NULL
pedigree	NULL
.	NULL

In	NULL
this	NULL
analysis	NULL
,	NULL
(	NULL
+	NULL
)	NULL
means	NULL
only	NULL
that	NULL
the	NULL
amplified	NULL
segment	NULL
from	NULL
intron	NULL
1	NULL
does	NULL
not	NULL
form	NULL
a	NULL
heteroduplex	NULL
with	NULL
DNA	NULL
from	NULL
an	NULL
affected	NULL
male	NULL
(	NULL
VI-O	NULL
)	NULL
and	NULL
therefore	NULL
is	NULL
the	NULL
same	NULL
allele	NULL
,	NULL
whereas	NULL
(	NULL
-	NULL
)	NULL
indicates	NULL
that	NULL
a	NULL
heteroduplex	NULL
is	NULL
formed	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
heterozygous	NULL
females	NULL
that	NULL
were	NULL
obligate	NULL
carriers	NULL
,	NULL
no	NULL
mixing	NULL
experiments	NULL
were	NULL
conducted	NULL
since	NULL
heteroduplexes	NULL
formed	NULL
from	NULL
the	NULL
two	NULL
different	NULL
autologous	NULL
alleles	NULL
.	NULL

A	NULL
recombination	NULL
event	NULL
involving	NULL
the	NULL
region	NULL
of	NULL
the	NULL
X	NULL
chromosome	NULL
containing	NULL
the	NULL
AR	NULL
gene	NULL
,	NULL
but	NULL
not	NULL
the	NULL
DXS	NULL
$	NULL
458	NULL
locus	NULL
or	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
was	NULL
observed	NULL
in	NULL
one	NULL
affected	NULL
male	NULL
(	NULL
VI-O	NULL
)	NULL
.	NULL

The	NULL
asterisk	NULL
at	NULL
VI-L	NULL
denotes	NULL
nonrandom	NULL
X-inactivation	NULL
without	NULL
carrier	NULL
status	NULL
.	NULL

This	NULL
finding	NULL
most	NULL
likely	NULL
represents	NULL
skewed	NULL
X-inactivation	NULL
that	NULL
is	NULL
found	NULL
occasionally	NULL
in	NULL
normal	NULL
femalFs	NULL
.	NULL

1172	NULL
Schmalstieg	NULL
et	NULL
al	NULL
.	NULL

e	NULL
A	NULL
portion	NULL
of	NULL
the	NULL
sequencing	NULL
gel	NULL
illustrating	NULL
the	NULL
mutation	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
sequence	NULL
shown	NULL
is	NULL
complementary	NULL
to	NULL
that	NULL
of	NULL
the	NULL
coding	NULL
strand	NULL
.	NULL

The	NULL
substitution	NULL
AT	NULL
was	NULL
demonstrated	NULL
in	NULL
the	NULL
patient	NULL
VI-O	NULL
,	NULL
but	NULL
not	NULL
in	NULL
his	NULL
normal	NULL
brother	NULL
.	NULL

garding	NULL
the	NULL
association	NULL
of	NULL
JAK-3	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Janus	NULL
family	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
,	NULL
with	NULL
y	NULL
.	NULL

(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
status	NULL
of	NULL
X	NULL
chromosome	NULL
inactivation	NULL
is	NULL
also	NULL
of	NULL
interest	NULL
in	NULL
this	NULL
disease	NULL
.	NULL

Investigations	NULL
of	NULL
X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
female	NULL
carriers	NULL
of	NULL
X-linked	NULL
immunodeficiency	NULL
diseases	NULL
have	NULL
been	NULL
useful	NULL
both	NULL
in	NULL
detecting	NULL
carriers	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
8	NULL
)	NULL
and	NULL
in	NULL
understanding	NULL
the	NULL
basis	NULL
of	NULL
some	NULL
of	NULL
those	NULL
defects	NULL
(	NULL
21-23	NULL
)	NULL
.	NULL

It	NULL
is	NULL
assumed	NULL
that	NULL
nonrandom	NULL
X	NULL
chromosome	NULL
inactivation	NULL
arises	NULL
from	NULL
a	NULL
survival	NULL
or	NULL
production	NULL
disadvantage	NULL
of	NULL
cells	NULL
in	NULL
which	NULL
the	NULL
defective	NULL
X	NULL
chromosome	NULL
is	NULL
the	NULL
active	NULL
one	NULL
(	NULL
6	NULL
,	NULL
21	NULL
)	NULL
.	NULL

In	NULL
that	NULL
regard	NULL
,	NULL
there	NULL
is	NULL
preferential	NULL
use	NULL
of	NULL
the	NULL
paternal	NULL
X	NULL
chromosome	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
in	NULL
most	NULL
female	NULL
carriers	NULL
of	NULL
XSCID	NULL
(	NULL
7	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
preferential	NULL
use	NULL
of	NULL
the	NULL
paternal	NULL
X	NULL
chromosome	NULL
in	NULL
blood	NULL
leukocytes	NULL
from	NULL
carrier	NULL
females	NULL
of	NULL
an	NULL
XSCID	NULL
variant	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
used	NULL
the	NULL
STR	NULL
,	NULL
(	NULL
CAG	NULL
)	NULL
,	NULL
,	NULL
in	NULL
the	NULL
androgen	NULL
receptor	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
differentially	NULL
methylated	NULL
in	NULL
active	NULL
and	NULL
inactive	NULL
X	NULL
chromosomes	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Obligate	NULL
female	NULL
carriers	NULL
of	NULL
this	NULL
novel	NULL
XCID	NULL
were	NULL
heterozygous	NULL
and	NULL
had	NULL
patterns	NULL
consistent	NULL
with	NULL
nonrandom	NULL
X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
variable	NULL
X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
PMNs	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
one	NULL
carrier	NULL
female	NULL
.	NULL

This	NULL
individual	NULL
,	NULL
surprisingly	NULL
,	NULL
utilized	NULL
the	NULL
paternal	NULL
X	NULL
chromosome	NULL
for	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
maternal	NULL
X	NULL
chromosome	NULL
for	NULL
B	NULL
cells	NULL
and	NULL
PMNs	NULL
.	NULL

One	NULL
possibility	NULL
for	NULL
this	NULL
finding	NULL
is	NULL
that	NULL
she	NULL
had	NULL
a	NULL
spontaneous	NULL
mutation	NULL
in	NULL
the	NULL
'	NULL
``	NULL
unaf-fected	NULL
``	NULL
X	NULL
chromosome	NULL
that	NULL
produced	NULL
a	NULL
second	NULL
defect	NULL
that	NULL
was	NULL
disadvantageous	NULL
for	NULL
the	NULL
survival	NULL
or	NULL
production	NULL
of	NULL
B	NULL
cells	NULL
and	NULL
PMNs	NULL
.	NULL

It	NULL
seems	NULL
more	NULL
likely	NULL
that	NULL
skewed	NULL
lyonization	NULL
towards	NULL
the	NULL
maternal	NULL
X	NULL
chromosome	NULL
occurred	NULL
in	NULL
this	NULL
carrier	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
this	NULL
scenario	NULL
,	NULL
a	NULL
preponderance	NULL
of	NULL
precursor	NULL
cells	NULL
would	NULL
utilize	NULL
the	NULL
maternal	NULL
X	NULL
chromosome	NULL
as	NULL
the	NULL
active	NULL
one	NULL
.	NULL

This	NULL
preponderance	NULL
would	NULL
overcome	NULL
the	NULL
disadvantage	NULL
this	NULL
chromosome	NULL
ordinarily	NULL
confers	NULL
on	NULL
the	NULL
production	NULL
or	NULL
survival	NULL
of	NULL
B	NULL
cells	NULL
.	NULL

Only	NULL
T	NULL
cells	NULL
of	NULL
paternal	NULL
origin	NULL
would	NULL
be	NULL
seen	NULL
because	NULL
the	NULL
gene	NULL
defect	NULL
is	NULL
more	NULL
lethal	NULL
for	NULL
T	NULL
cells	NULL
.	NULL

Although	NULL
the	NULL
chromosome	NULL
carrying	NULL
the	NULL
gene	NULL
defect	NULL
for	NULL
XCID	NULL
was	NULL
presumably	NULL
employed	NULL
for	NULL
both	NULL
B	NULL
cells	NULL
and	NULL
PMNs	NULL
,	NULL
no	NULL
defect	NULL
in	NULL
function	NULL
was	NULL
detected	NULL
for	NULL
either	NULL
cell	NULL
type	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
this	NULL
finding	NULL
suggests	NULL
that	NULL
although	NULL
the	NULL
gene	NULL
defect	NULL
responsible	NULL
for	NULL
XCID	NULL
affects	NULL
the	NULL
production	NULL
or	NULL
survival	NULL
of	NULL
both	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
chief	NULL
effect	NULL
is	NULL
directed	NULL
at	NULL
T	NULL
cell	NULL
function	NULL
.	NULL

This	NULL
does	NULL
not	NULL
preclude	NULL
more	NULL
subtle	NULL
defects	NULL
in	NULL
B	NULL
cell	NULL
function	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
patients	NULL
with	NULL
XCID	NULL
demonstrate	NULL
a	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
gene	NULL
that	NULL
codes	NULL
for	NULL
the	NULL
intracellular	NULL
portion	NULL
of	NULL
the	NULL
y.	NULL
protein	NULL
.	NULL

This	NULL
newly	NULL
recognized	NULL
mutation	NULL
promises	NULL
to	NULL
provide	NULL
new	NULL
insights	NULL
into	NULL
the	NULL
function	NULL
of	NULL
the	NULL
IL-2R	NULL
y	NULL
chain	NULL
.	NULL

The	NULL
explanation	NULL
for	NULL
the	NULL
disparate	NULL
clinical	NULL
findings	NULL
in	NULL
XCID	NULL
and	NULL
XSCID	NULL
remains	NULL
an	NULL
important	NULL
question	NULL
.	NULL

There	NULL
is	NULL
a	NULL
precedent	NULL
in	NULL
that	NULL
very	NULL
different	NULL
symptomatology	NULL
also	NULL
results	NULL
from	NULL
specific	NULL
mutations	NULL
in	NULL
the	NULL
B	NULL
cell	NULL
tyrosine	NULL
kinase	NULL
gene	NULL
in	NULL
human	NULL
X-linked	NULL
agammaglobulinemia	NULL
and	NULL
CBA/N	NULL
mice	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

However	NULL
,	NULL
because	NULL
y	NULL
,	NULL
is	NULL
not	NULL
only	NULL
a	NULL
part	NULL
of	NULL
the	NULL
IL-2R	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
19	NULL
,	NULL
29	NULL
)	NULL
,	NULL
but	NULL
also	NULL
a	NULL
constituent	NULL
of	NULL
the	NULL
IL-4	NULL
(	NULL
30	NULL
)	NULL
,	NULL
IL-7	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
,	NULL
IL-9	NULL
(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
IL-15	NULL
(	NULL
33	NULL
)	NULL
receptors	NULL
,	NULL
the	NULL
task	NULL
of	NULL
unraveling	NULL
the	NULL
molecular	NULL
patho-genesis	NULL
of	NULL
the	NULL
resultant	NULL
immunodeficiencies	NULL
in	NULL
this	NULL
XCID	NULL
will	NULL
be	NULL
complex	NULL
.	NULL

However	NULL
,	NULL
since	NULL
mature	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
may	NULL
be	NULL
obtained	NULL
from	NULL
the	NULL
affected	NULL
males	NULL
,	NULL
and	NULL
transgenic	NULL
animals	NULL
with	NULL
the	NULL
disease	NULL
mutation	NULL
may	NULL
be	NULL
constructed	NULL
,	NULL
it	NULL
may	NULL
be	NULL
possible	NULL
in	NULL
the	NULL
near	NULL
future	NULL
to	NULL
understand	NULL
further	NULL
the	NULL
consequences	NULL
of	NULL
this	NULL
defect	NULL
upon	NULL
the	NULL
development	NULL
and	NULL
function	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Mary	NULL
Douglas	NULL
for	NULL
her	NULL
kind	NULL
assistance	NULL
in	NULL
preparing	NULL
the	NULL
B-lymphoblastoid	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
Dr.	NULL
O.	NULL
Wesley	NULL
McBride	NULL
for	NULL
critical	NULL
comments	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
A.	NULL
P.	NULL
Lookingbill	NULL
,	NULL
Dr.	NULL
H.	NULL
M.	NULL
Rosenblatt	NULL
,	NULL
and	NULL
Dr.	NULL
R.	NULL
Kelly	NULL
for	NULL
their	NULL
clinical	NULL
assistance	NULL
with	NULL
these	NULL
patients	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
the	NULL
John	NULL
Sealy	NULL
Memorial	NULL
Endowment	NULL
to	NULL
the	NULL
University	NULL
of	NULL
Texas	NULL
Medical	NULL
Branch	NULL
in	NULL
Galveston	NULL
,	NULL
Texas	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Brooks	NULL
,	NULL
E.	NULL
G.	NULL
,	NULL
F.	NULL
C.	NULL
Schmaistieg	NULL
,	NULL
D.	NULL
P.	NULL
Wirt	NULL
,	NULL
H.	NULL
M.	NULL
Rosenblatt	NULL
,	NULL
L.	NULL
T.	NULL
Adkins	NULL
,	NULL
D.	NULL
P.	NULL
Lookingbill	NULL
,	NULL
H.	NULL
E.	NULL
Rudloff	NULL
,	NULL
T.	NULL
A.	NULL
Rakusan	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Goldman	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
novel	NULL
X-linked	NULL
combined	NULL
immunodeficiency	NULL
disease	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

86:1623-1631	NULL
.	NULL

2	NULL
.	NULL

Schmalstieg	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
D.	NULL
P.	NULL
Wirt	NULL
,	NULL
L.	NULL
T.	NULL
Adkins	NULL
,	NULL
E.	NULL
G.	NULL
Brooks	NULL
,	NULL
S.	NULL
D.	NULL
Stansberry	NULL
,	NULL
L.	NULL
E.	NULL
Swischuk	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Goldman	NULL
.	NULL

1992	NULL
.	NULL

Postnatal	NULL
development	NULL
of	NULL
T	NULL
lymphocytes	NULL
in	NULL
a	NULL
novel	NULL
X-linked	NULL
immunodeficiency	NULL
disease	NULL
.	NULL

Clin	NULL
.	NULL

Immunol	NULL
.	NULL

Immunopa-thol	NULL
.	NULL

64:71	NULL
3	NULL
.	NULL

Goldman	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
K.	NULL
H.	NULL
Palkowetz	NULL
,	NULL
H.	NULL
E.	NULL
Rudloff	NULL
,	NULL
E.	NULL
G.	NULL
Brooks	NULL
,	NULL
and	NULL
F.	NULL
C.	NULL
Schmalstieg	NULL
.	NULL

1992	NULL
.	NULL

Repertoire	NULL
of	NULL
Va	NULL
and	NULL
V/	NULL
regions	NULL
of	NULL
T	NULL
cell	NULL
antigen	NULL
receptors	NULL
on	NULL
CD4+	NULL
and	NULL
CD8+	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
novel	NULL
X-linked	NULL
combined	NULL
immunodeficiency	NULL
disease	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22:1103-1106	NULL
.	NULL

4	NULL
.	NULL

La-Spada	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
E.	NULL
M.	NULL
Wilson	NULL
,	NULL
D.	NULL
B.	NULL
Lubahn	NULL
,	NULL
A.	NULL
E.	NULL
Harding	NULL
,	NULL
and	NULL
K.	NULL
H.	NULL
Fischbeck	NULL
.	NULL

1991	NULL
.	NULL

Androgen	NULL
receptor	NULL
gene	NULL
mutations	NULL
in	NULL
X-linked	NULL
spinal	NULL
and	NULL
bulbar	NULL
muscular	NULL
atrophy	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

352:77-79	NULL
.	NULL

5	NULL
.	NULL

Allen	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
H.	NULL
Y.	NULL
Zoghbi	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Moseley	NULL
,	NULL
H.	NULL
M.	NULL
Rosenblatt	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Belmont	NULL
.	NULL

1992	NULL
.	NULL

Methylation	NULL
of	NULL
Hpall	NULL
and	NULL
Hhal	NULL
sites	NULL
near	NULL
the	NULL
polymorphic	NULL
CAG	NULL
repeat	NULL
in	NULL
the	NULL
human	NULL
androgen-receptor	NULL
gene	NULL
correlates	NULL
with	NULL
X	NULL
chromosome	NULL
inactivation	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

51:1229-1239	NULL
.	NULL

6	NULL
.	NULL

Conley	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
A.	NULL
Lavoie	NULL
,	NULL
C.	NULL
Briggs	NULL
,	NULL
P.	NULL
Brown	NULL
,	NULL
C.	NULL
Guerra	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Puck	NULL
.	NULL

1988	NULL
.	NULL

Nonrandom	NULL
X	NULL
chromosome	NULL
inactivation	NULL
in	NULL
B	NULL
cells	NULL
from	NULL
carriers	NULL
of	NULL
X	NULL
chromosome-linked	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

85:3090-3094	NULL
.	NULL

7	NULL
.	NULL

Puck	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
R.	NULL
L.	NULL
Nussbaum	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Conley	NULL
.	NULL

1987	NULL
.	NULL

Carrier	NULL
detection	NULL
in	NULL
X-linked	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
based	NULL
on	NULL
patterns	NULL
of	NULL
X	NULL
chromosome	NULL
inactivation	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

79:1395-1400	NULL
.	NULL

8	NULL
.	NULL

Puck	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
C.	NULL
C.	NULL
Stewart	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Nussbaum	NULL
.	NULL

1992	NULL
.	NULL

Maximum-likelihood	NULL
analysis	NULL
of	NULL
human	NULL
T-cell	NULL
X	NULL
chromosome	NULL
inactivation	NULL
patterns	NULL
:	NULL
normal	NULL
women	NULL
versus	NULL
carriers	NULL
of	NULL
X-linked	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

50:742-748	NULL
.	NULL

9	NULL
.	NULL

Noguchi	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Yi	NULL
,	NULL
H.	NULL
M.	NULL
Rosenblatt	NULL
,	NULL
A.	NULL
H.	NULL
Filipovich	NULL
,	NULL
S.	NULL
Adelstein	NULL
,	NULL
W.	NULL
S.	NULL
Modi	NULL
,	NULL
W.	NULL
McBride	NULL
O	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
y	NULL
chain	NULL
mutation	NULL
results	NULL
in	NULL
X-linked	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
in	NULL
humans	NULL
.	NULL

Cell	NULL
.	NULL

73:147-157	NULL
.	NULL

10	NULL
.	NULL

Noguchi	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Adelstein	NULL
,	NULL
X.	NULL
Cao	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
y	NULL
chain	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:13601-13608	NULL
.	NULL

11	NULL
.	NULL

Weber	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
A.	NULL
E.	NULL
Kwitek	NULL
,	NULL
P.	NULL
E.	NULL
May	NULL
,	NULL
M.	NULL
H.	NULL
Polymeropoulos	NULL
,	NULL
and	NULL
S.	NULL
Ledbetter	NULL
.	NULL

1990	NULL
.	NULL

Dinucleotide	NULL
repeat	NULL
polymorphisms	NULL
at	NULL
the	NULL
DXS453	NULL
,	NULL
DXS454	NULL
,	NULL
and	NULL
DXS458	NULL
loci	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:4037	NULL
.	NULL

12	NULL
.	NULL

Edwards	NULL
,	NULL
A.	NULL
,	NULL
H.	NULL
A.	NULL
Hammond	NULL
,	NULL
L.	NULL
Hin	NULL
,	NULL
C.	NULL
T.	NULL
Caskey	NULL
,	NULL
and	NULL
R.	NULL
Chakraborty	NULL
.	NULL

1992	NULL
.	NULL

Genetic	NULL
variation	NULL
at	NULL
five	NULL
trimeric	NULL
and	NULL
tetrameric	NULL
tandem	NULL
repeat	NULL
loci	NULL
in	NULL
four	NULL
human	NULL
population	NULL
groups	NULL
.	NULL

Genomics	NULL
.	NULL

12:241-253	NULL
.	NULL

13	NULL
.	NULL

Boyum	NULL
,	NULL
A	NULL
.	NULL

1968	NULL
.	NULL

Isolation	NULL
of	NULL
mononuclear	NULL
cells	NULL
and	NULL
granulocytes	NULL
from	NULL
human	NULL
blood	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

21	NULL
(	NULL
suppl	NULL
.	NULL

97	NULL
)	NULL
:77-89	NULL
.	NULL

14	NULL
.	NULL

Manyonda	NULL
,	NULL
I.	NULL
T.	NULL
,	NULL
A.	NULL
J.	NULL
Soltys	NULL
,	NULL
and	NULL
F.	NULL
C.	NULL
Hay	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
critical	NULL
evaluation	NULL
of	NULL
the	NULL
magnetic	NULL
cell	NULL
sorter	NULL
and	NULL
its	NULL
use	NULL
in	NULL
the	NULL
positive	NULL
and	NULL
negative	NULL
selection	NULL
of	NULL
CD4SRO+	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
.	NULL

149:1-10	NULL
.	NULL

15	NULL
.	NULL

Straub	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Zubler	NULL
.	NULL

1989	NULL
.	NULL

Immortalization	NULL
of	NULL
EBV-infected	NULL
B	NULL
cells	NULL
is	NULL
not	NULL
influenced	NULL
by	NULL
exogenous	NULL
signals	NULL
acting	NULL
on	NULL
B	NULL
cell	NULL
proliferation	NULL
.	NULL

Effects	NULL
of	NULL
mutant	NULL
EL-4	NULL
thymoma	NULL
cells	NULL
and	NULL
transforming	NULL
growth	NULL
factor-beta	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:87-93	NULL
.	NULL

16	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
.	NULL

17	NULL
.	NULL

Vogelstein	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
R.	NULL
Fearon	NULL
,	NULL
S.	NULL
R.	NULL
Hamilton	NULL
,	NULL
A.	NULL
C.	NULL
Preisinger	NULL
,	NULL
H.	NULL
F.	NULL
Willard	NULL
,	NULL
A.	NULL
M.	NULL
Michelson	NULL
,	NULL
A.	NULL
D.	NULL
Riggs	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
.	NULL

1987	NULL
.	NULL

Clonal	NULL
analysis	NULL
using	NULL
recombinant	NULL
DNA	NULL
probes	NULL
from	NULL
the	NULL
X-chromosome	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

47:4806-4813	NULL
.	NULL

18	NULL
.	NULL

Huang	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
R.	NULL
W.	NULL
Cottingham	NULL
,	NULL
Jr.	NULL
,	NULL
D.	NULL
H.	NULL
Ledbetter	NULL
,	NULL
and	NULL
H.	NULL
Y.	NULL
Zoghbi	NULL
.	NULL

1992	NULL
.	NULL

Genetic	NULL
mapping	NULL
of	NULL
four	NULL
dinucleotide	NULL
repeat	NULL
loci	NULL
,	NULL
DXS453	NULL
,	NULL
DXS458	NULL
,	NULL
DXS	NULL
$	NULL
454	NULL
,	NULL
and	NULL
DXS424	NULL
,	NULL
on	NULL
the	NULL
X	NULL
chromosome	NULL
using	NULL
multiplex	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Genomics	NULL
.	NULL

13:375-380	NULL
.	NULL

19	NULL
.	NULL

Takeshita	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Asao	NULL
,	NULL
K.	NULL
Ohtani	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
S.	NULL
Kumaki	NULL
,	NULL
N.	NULL
Tanaka	NULL
,	NULL
H.	NULL
Munakata	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1992	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
y	NULL
chain	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
receptor	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

257:379-382	NULL
.	NULL

20	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
M.	NULL
Kawamura	NULL
,	NULL
C.	NULL
M.	NULL
Bacon	NULL
,	NULL
M.	NULL
Friedman	NULL
,	NULL
M.	NULL
Berg	NULL
,	NULL
D.	NULL
W.	NULL
McVicar	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Goldman	NULL
,	NULL
F.	NULL
C.	NULL
Schmalstieg	NULL
,	NULL
J.	NULL
N.	NULL
Thle	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1994	NULL
.	NULL

Interaction	NULL
of	NULL
IL-2	NULL
receptor	NULL
3	NULL
and	NULL
y	NULL
,	NULL
chains	NULL
with	NULL
JAK1	NULL
and	NULL
JAK3	NULL
,	NULL
respec-tively	NULL
:	NULL
defective	NULL
y	NULL
,	NULL
-JAK3	NULL
association	NULL
in	NULL
XSCID	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

266:1042-1044	NULL
.	NULL

21.	NULL
Cooper	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Lawton	NULL
.	NULL

1972	NULL
.	NULL

Circulating	NULL
B-cells	NULL
in	NULL
patients	NULL
with	NULL
immunodeficiency	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

69:513-528	NULL
.	NULL

22	NULL
.	NULL

Vetrie	NULL
,	NULL
D.	NULL
,	NULL
I.	NULL
Vorechovsky	NULL
,	NULL
P.	NULL
Sideras	NULL
,	NULL
J.	NULL
Holland	NULL
,	NULL
A.	NULL
Davies	NULL
,	NULL
F.	NULL
Flinter	NULL
,	NULL
L.	NULL
Hammarstrom	NULL
,	NULL
C.	NULL
Kinnon	NULL
,	NULL
R.	NULL
Levinsky	NULL
,	NULL
M.	NULL
Bobrow	NULL
,	NULL
C.	NULL
I.	NULL
E.	NULL
Smith	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Bentley	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
gene	NULL
involved	NULL
in	NULL
X-linked	NULL
agammaglobulinaemia	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
src	NULL
family	NULL
of	NULL
protein-tyrosine	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

361:226-233	NULL
.	NULL

23	NULL
.	NULL

Tsukada	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
C.	NULL
Saffran	NULL
,	NULL
D.	NULL
J.	NULL
Rawlings	NULL
,	NULL
O.	NULL
Parolini	NULL
,	NULL
R.	NULL
C.	NULL
Allen	NULL
,	NULL
I.	NULL
Klisak	NULL
,	NULL
R.	NULL
S.	NULL
Sparkes	NULL
,	NULL
H.	NULL
Kubagawa	NULL
,	NULL
T.	NULL
Mohandas	NULL
,	NULL
S.	NULL
Quan	NULL
,	NULL
J.	NULL
W.	NULL
Belmont	NULL
,	NULL
M.	NULL
D.	NULL
Cooper	NULL
,	NULL
M.	NULL
E.	NULL
Conley	NULL
,	NULL
and	NULL
O.	NULL
N.	NULL
Witte	NULL
.	NULL

1993	NULL
.	NULL

Deficient	NULL
expression	NULL
of	NULL
a	NULL
B	NULL
cell	NULL
cytoplasmic	NULL
tyrosine	NULL
kinase	NULL
in	NULL
human	NULL
X-linked	NULL
agammaglobulinemia	NULL
.	NULL

Cell	NULL
.	NULL

72:279-290	NULL
.	NULL

24	NULL
.	NULL

Conley	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Puck	NULL
.	NULL

1988	NULL
.	NULL

Definition	NULL
of	NULL
the	NULL
gene	NULL
loci	NULL
in	NULL
X-linked	NULL
immunodeficiencies	NULL
.	NULL

Immunol	NULL
.	NULL

Invest	NULL
.	NULL

17:425-463	NULL
.	NULL

25.	NULL
de	NULL
Saint-Basile	NULL
,	NULL
G.	NULL
,	NULL
F.	NULL
Le-Deist	NULL
,	NULL
M.	NULL
Caniglia	NULL
,	NULL
Y.	NULL
Lebranchu	NULL
,	NULL
C.	NULL
Griscelli	NULL
,	NULL
and	NULL
A.	NULL
Fischer	NULL
.	NULL

1992	NULL
.	NULL

Genetic	NULL
study	NULL
of	NULL
a	NULL
new	NULL
X-linked	NULL
recessive	NULL
immunodeficiency	NULL
syndrome	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

89:861~-866	NULL
.	NULL

26	NULL
.	NULL

Gale	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
H.	NULL
Wheadon	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Linch	NULL
.	NULL

1991	NULL
.	NULL

X-chromosome	NULL
inactivation	NULL
patterns	NULL
using	NULL
HPRT	NULL
and	NULL
PGK	NULL
polymorphisms	NULL
in	NULL
haematologically	NULL
normal	NULL
and	NULL
post-chemotherapy	NULL
females	NULL
.	NULL

Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

79:193-197	NULL
.	NULL

27	NULL
.	NULL

Thomas	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
P.	NULL
Sideras	NULL
,	NULL
C.	NULL
I.	NULL
E.	NULL
Smith	NULL
,	NULL
I.	NULL
Vorechovsky	NULL
,	NULL
V.	NULL
Chapman	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1993	NULL
.	NULL

X-linked	NULL
agammaglobulinemia	NULL
and	NULL
X-linked	NULL
immunodeficiency	NULL
genes	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

261:355-358	NULL
.	NULL

28	NULL
.	NULL

Rawlings	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
D.	NULL
C.	NULL
Saffran	NULL
,	NULL
S.	NULL
Tsukada	NULL
,	NULL
D.	NULL
A.	NULL
Largaespada	NULL
,	NULL
F.	NULL
C.	NULL
Grimaldi	NULL
,	NULL
L.	NULL
Cohen	NULL
,	NULL
R.	NULL
N.	NULL
Mohr	NULL
,	NULL
J.	NULL
F.	NULL
Bazan	NULL
,	NULL
M.	NULL
Howard	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
and	NULL
O.	NULL
N.	NULL
Wittig	NULL
.	NULL

1993	NULL
.	NULL

Mutation	NULL
of	NULL
unique	NULL
region	NULL
of	NULL
Bruton	NULL
's	NULL
tyrosine	NULL
kinase	NULL
in	NULL
immunodeficient	NULL
XID	NULL
mice	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

261:358-361	NULL
.	NULL

29	NULL
.	NULL

Cao	NULL
,	NULL
X.	NULL
,	NULL
C.	NULL
A.	NULL
Kozak	NULL
,	NULL
Y.	NULL
J.	NULL
Liu	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
E.	NULL
O'Connell	NULL
,	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
cDNAs	NULL
encoding	NULL
the	NULL
murine	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
IL-2R	NULL
)	NULL
y	NULL
chain	NULL
:	NULL
chromosomal	NULL
mapping	NULL
and	NULL
tissue	NULL
specificity	NULL
of	NULL
IL-2R	NULL
y	NULL
chain	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

90:8464-8468	NULL
.	NULL

30	NULL
.	NULL

Kondo	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Takeshita	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
S.	NULL
Watanabe	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1993	NULL
.	NULL

Sharing	NULL
of	NULL
the	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
receptor	NULL
y	NULL
chain	NULL
between	NULL
receptors	NULL
for	NULL
IL-2	NULL
and	NULL
IL-4	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

262:1874-1877	NULL
.	NULL

31	NULL
.	NULL

Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Nakamura	NULL
,	NULL
S.	NULL
M.	NULL
Russell	NULL
,	NULL
S.	NULL
F.	NULL
Ziegler	NULL
,	NULL
M.	NULL
Tsang	NULL
,	NULL
X.	NULL
Cao	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
-y	NULL
chain	NULL
:	NULL
a	NULL
functional	NULL
component	NULL
of	NULL
the	NULL
interleukin-7	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

262:1877-1880	NULL
.	NULL

32	NULL
.	NULL

Kondo	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Takeshita	NULL
,	NULL
M.	NULL
Higuchi	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
T.	NULL
Sudo	NULL
,	NULL
S.	NULL
Nishi-kawa	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
participation	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
y	NULL
chain	NULL
in	NULL
IL-7	NULL
receptor	NULL
complexes	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

263:1453-1454	NULL
.	NULL

33	NULL
.	NULL

Giri	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
M.	NULL
Ahdleh	NULL
,	NULL
J.	NULL
Eisenman	NULL
,	NULL
K.	NULL
Shanebeck	NULL
,	NULL
S.	NULL
Grabstein	NULL
,	NULL
A.	NULL
Kumake	NULL
,	NULL
L.	NULL
Nmaen	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
D.	NULL
Cosman	NULL
,	NULL
and	NULL
D.	NULL
Anderson	NULL
.	NULL

1994	NULL
.	NULL

Utilization	NULL
of	NULL
the	NULL
3	NULL
and	NULL
y	NULL
chains	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
by	NULL
the	NULL
novel	NULL
cytokine	NULL
IL-15	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

13:2822-2830	NULL
.	NULL

Moderate	NULL
X-linked	NULL
Combined	NULL
Immunodeficiency	NULL
1173	NULL

